ClinicalTrials.govpublic full text
Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma
melanoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 407758
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.